Thomas Brigman is a Principal Scientist in Cellular Biomarkers & Genomics at GSK since 2025, where they lead the development and execution of biomarker assays to support clinical programs. Previously, they held roles as a Senior Staff Scientist at Incyte from 2018 to 2021, and as a Scientist at Eurofins from 2016 to 2018. Thomas also contributed to the field as a Scientist at Century Therapeutics, Inc. during 2024-2025. They are currently pursuing a Bachelor of Science in Biology at York College of Pennsylvania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices